A Bayesian Joint Model of Longitudinal Kidney Disease Progression, Recurrent Cardiovascular Events, and Terminal Event in Patients with Chronic Kidney Disease
Related Posts
Kondengadan SM, Park Y, Byun H, Abdi R. Antibody-drug conjugates as immune modulators: current landscape, challenges, and opportunities. J Control Release. 2026 Nov 5:115526. doi:[...]
Sureshkumar K, Klein JA, Kumar D, Costa N, Glehn-Ponsirenas R, Chuang P, Shen L, Lu J, Wojciechowski D, Jain P, Huang Y, Wiseman A, Huang[...]
Fu Q, Liu H. Advances in Biomarker Discovery for Cardiovascular Disease. Biomedicines. 2026 Sep 23;14(10):2144. doi: 10.3390/biomedicines14102144. PMID: 42939951; PMCID: PMC13701612.